Skip to main content
OpenTrials
Completed

NCT Number: NCT04414085

The Clinical Significance of Biochemical 11 Deoxycortisol Levels

data from charts regarding clinical characteristics and androgens levels from first to last visit were collected

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

10 year–18 year

Sex eligibility

Female

Study type

Observational

Primary location

Assaf Harofeh Medical Center

Ẕerifin, 70300, Israel

About this study

data from charts regarding clinical characteristics and androgens levels from first to last visit were collected Female patients only ages 10-18 years who were referred to the combined gynecology endocrinology adolescents clinic

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

age 10-18 years referred to gynecology endocrinology adolescents clinic

Exclusion criteria

no data available in chart no blood work available

Treatment and study plan

Primary outcomes

  1. Presence of hyperandrogenism signs (1 to 3 categorized)

    Time frame: 3 years

    hirsuitism, acne, menses, each marked as 0 or 1 (none or present)

Sponsors and collaborators

Lead sponsor

Assaf Harofeh MC

Other Gov

Registry information

Official study title

The Clinical Significance of Biochemical Polymorphism in the 11 Deoxycortisol Levels Before and After Stimulation With Adrenocorticotrofin

Important dates

Study start
2015
Primary completion
2020
Study completion
2020
First posted
Jun 4, 2020
Registry last updated
Jun 4, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.